These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 9209731

  • 1. Limitations of controlled augmentation trials in schizophrenia.
    Stern RG, Schmeidler J, Davidson M.
    Biol Psychiatry; 1997 Jul 15; 42(2):138-43. PubMed ID: 9209731
    [Abstract] [Full Text] [Related]

  • 2. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW, Gueorguieva RV, Baker CB, Makuch RW.
    Arch Gen Psychiatry; 2005 Sep 15; 62(9):961-70. PubMed ID: 16143728
    [Abstract] [Full Text] [Related]

  • 3. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G, Hummer M, Widschwendter C, Fleischhacker WW.
    Arch Gen Psychiatry; 2005 Dec 15; 62(12):1305-12. PubMed ID: 16330718
    [Abstract] [Full Text] [Related]

  • 4. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
    Lerner V, Libov I, Kotler M, Strous RD.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan 15; 28(1):89-98. PubMed ID: 14687862
    [Abstract] [Full Text] [Related]

  • 5. A prospective survey on drug choice for prescriptions for admitted patients with schizophrenia.
    Ito C, Kubota Y, Sato M.
    Psychiatry Clin Neurosci; 1999 Oct 15; 53 Suppl():S35-40. PubMed ID: 10560896
    [Abstract] [Full Text] [Related]

  • 6. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.
    Mishara AL, Goldberg TE.
    Biol Psychiatry; 2004 May 15; 55(10):1013-22. PubMed ID: 15121486
    [Abstract] [Full Text] [Related]

  • 7. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
    Taylor DM, Smith L.
    Acta Psychiatr Scand; 2009 Jun 15; 119(6):419-25. PubMed ID: 19245679
    [Abstract] [Full Text] [Related]

  • 8. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS, Gibel A, Ratner Y, Tsinovoy G, Strous RD.
    J Clin Psychopharmacol; 2006 Oct 15; 26(5):495-9. PubMed ID: 16974191
    [Abstract] [Full Text] [Related]

  • 9. Management of treatment resistant schizophrenia unresponsive to clozapine.
    Barnes TR, McEvedy CJ, Nelson HE.
    Br J Psychiatry Suppl; 1996 Dec 15; (31):31-40. PubMed ID: 8968653
    [No Abstract] [Full Text] [Related]

  • 10. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Assion HJ, Reinbold H, Lemanski S, Basilowski M, Juckel G.
    Pharmacopsychiatry; 2008 Jan 15; 41(1):24-8. PubMed ID: 18203048
    [Abstract] [Full Text] [Related]

  • 11. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S, Safarcherati A, Amini H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb 15; 29(2):253-9. PubMed ID: 15694232
    [Abstract] [Full Text] [Related]

  • 12. [Quetiapine in the treatment of acute mania].
    Bräunig P.
    Psychiatr Prax; 2006 Mar 15; 33 Suppl 1():S27-31. PubMed ID: 16511728
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hospitalization rates before and after initiation of paliperidone ER in patients with schizophrenia: results from open-label extensions of the US double-blind trials.
    Janicak PG, Wu JH, Mao L.
    Curr Med Res Opin; 2008 Jun 15; 24(6):1807-15. PubMed ID: 18559166
    [Abstract] [Full Text] [Related]

  • 17. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
    Fowler JA, Bettinger TL, Argo TR.
    Clin Ther; 2008 Feb 15; 30(2):231-48. PubMed ID: 18343262
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ, Riedel M, Müller N, Fischer W, Kohnen R.
    Pharmacopsychiatry; 2004 Nov 15; 37(6):270-8. PubMed ID: 15551193
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.